907 related articles for article (PubMed ID: 16250003)
1. Update of the molecular basis of familial hypercholesterolemia in The Netherlands.
Fouchier SW; Kastelein JJ; Defesche JC
Hum Mutat; 2005 Dec; 26(6):550-6. PubMed ID: 16250003
[TBL] [Abstract][Full Text] [Related]
2. Autosomal dominant type IIa hypercholesterolemia: evaluation of the respective contributions of LDLR and APOB gene defects as well as a third major group of defects.
Saint-Jore B; Varret M; Dachet C; Rabès JP; Devillers M; Erlich D; Blanchard P; Krempf M; Mathé D; Chanu B; Jacotot B; Farnier M; Bonaïti-Péllié C; Junien C; Boileau C
Eur J Hum Genet; 2000 Aug; 8(8):621-30. PubMed ID: 10952765
[TBL] [Abstract][Full Text] [Related]
3. Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting.
Civeira F; Jarauta E; Cenarro A; García-Otín AL; Tejedor D; Zambón D; Mallen M; Ros E; Pocoví M
J Am Coll Cardiol; 2008 Nov; 52(19):1546-53. PubMed ID: 19007590
[TBL] [Abstract][Full Text] [Related]
4. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
5. Influence of LDL receptor gene mutations and the R3500Q mutation of the apoB gene on lipoprotein phenotype of familial hypercholesterolemic patients from a South European population.
Real JT; Chaves FJ; Ejarque I; García-García AB; Valldecabres C; Ascaso JF; Armengod ME; Carmena R
Eur J Hum Genet; 2003 Dec; 11(12):959-65. PubMed ID: 14508510
[TBL] [Abstract][Full Text] [Related]
6. Portuguese Familial Hypercholesterolemia Study: presentation of the study and preliminary results.
Bourbon M; Rato Q;
Rev Port Cardiol; 2006 Nov; 25(11):999-1013. PubMed ID: 17274457
[TBL] [Abstract][Full Text] [Related]
7. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
[TBL] [Abstract][Full Text] [Related]
8. The molecular basis of familial hypercholesterolemia in The Netherlands.
Fouchier SW; Defesche JC; Umans-Eckenhausen MW; Kastelein JP
Hum Genet; 2001 Dec; 109(6):602-15. PubMed ID: 11810272
[TBL] [Abstract][Full Text] [Related]
9. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
[TBL] [Abstract][Full Text] [Related]
10. Mutation analysis in 46 German families with familial hypercholesterolemia: identification of 8 new mutations. Mutations in brief no. 226. Online.
Ebhardt M; Schmidt H; Doerk T; Tietge U; Haas R; Manns MP; Schmidtke J; Stuhrmann M
Hum Mutat; 1999; 13(3):257. PubMed ID: 10090484
[TBL] [Abstract][Full Text] [Related]
11. [Identification of a novel splice mutation of low density lipoprotein receptor gene in a Chinese family with familial hypercholesterolemia].
Lin J; Wang LY; Liu S; Pan XD; Du LP; Shi FR; Qin YW; Zhao Q; Guo HY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb; 21(1):14-8. PubMed ID: 14767901
[TBL] [Abstract][Full Text] [Related]
12. Familial defective apolipoprotein B-100.
Hansen PS
Dan Med Bull; 1998 Sep; 45(4):370-82. PubMed ID: 9777289
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of familial hypercholesterolemia in German and Greek patients.
Dedoussis GV; Genschel J; Bochow B; Pitsavos C; Skoumas J; Prassa M; Lkhagvasuren S; Toutouzas P; Vogt A; Kassner U; Thomas HP; Schmidt H
Hum Mutat; 2004 Mar; 23(3):285-6. PubMed ID: 14974088
[TBL] [Abstract][Full Text] [Related]
14. Functionality of sequence variants in the genes coding for the low-density lipoprotein receptor and apolipoprotein B in individuals with inherited hypercholesterolemia.
Huijgen R; Kindt I; Fouchier SW; Defesche JC; Hutten BA; Kastelein JJ; Vissers MN
Hum Mutat; 2010 Jun; 31(6):752-60. PubMed ID: 20506408
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of the LDL receptor and APOB genes in Mexican individuals with autosomal dominant hypercholesterolemia.
Vaca G; Vàzquez A; Magaña MT; Ramìrez ML; Dàvalos IP; Martìnez E; Marìn B; Carrillo G
Atherosclerosis; 2011 Oct; 218(2):391-6. PubMed ID: 21722902
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of familial hypercholesterolemia in Brazil: Identification of seven novel LDLR gene mutations.
Salazar LA; Hirata MH; Cavalli SA; Nakandakare ER; Forti N; Diament J; Giannini SD; Bertolami MC; Hirata RD
Hum Mutat; 2002 Apr; 19(4):462-3. PubMed ID: 11933210
[TBL] [Abstract][Full Text] [Related]
17. Common mutations of familial hypercholesterolemia patients in Taiwan: characteristics and implications of migrations from southeast China.
Chiou KR; Charng MJ
Gene; 2012 Apr; 498(1):100-6. PubMed ID: 22353362
[TBL] [Abstract][Full Text] [Related]
18. Novel mutations identification in exon 4 of LDLR gene in patients with moderate hypercholesterolemia in a Venezuelan population.
Arráiz N; Bermúdez V; Rondon N; Reyes F; Borjas L; Solís E; Mujica E; Prieto C; Reyna N; Velasco M
Am J Ther; 2010; 17(3):325-9. PubMed ID: 20019594
[TBL] [Abstract][Full Text] [Related]
19. Familial defective apolipoprotein B versus familial hypercholesterolemia: an assessment of risk.
Fouchier SW; Defesche JC; Kastelein JJ; Sijbrands EJ
Semin Vasc Med; 2004 Aug; 4(3):259-64. PubMed ID: 15630635
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of familial hypercholesterolemia in Spain: identification of 39 novel and 77 recurrent mutations in LDLR.
Mozas P; Castillo S; Tejedor D; Reyes G; Alonso R; Franco M; Saenz P; Fuentes F; Almagro F; Mata P; Pocoví M
Hum Mutat; 2004 Aug; 24(2):187. PubMed ID: 15241806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
